57 related articles for article (PubMed ID: 10616976)
21. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer].
Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
Pneumologie; 2000 Aug; 54(8):355-60. PubMed ID: 11008478
[TBL] [Abstract][Full Text] [Related]
22. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer.
Kubuschok B; Passlick B; Izbicki JR; Thetter O; Pantel K
J Clin Oncol; 1999 Jan; 17(1):19-24. PubMed ID: 10458213
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.
Passlick B; Izbicki JR; Kubuschok B; Nathrath W; Thetter O; Pichlmeier U; Schweiberer L; Riethmüller G; Pantel K
J Clin Oncol; 1994 Sep; 12(9):1827-32. PubMed ID: 8083707
[TBL] [Abstract][Full Text] [Related]
24. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
[TBL] [Abstract][Full Text] [Related]
25. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
[TBL] [Abstract][Full Text] [Related]
26. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer.
Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
Ann Thorac Surg; 1999 Dec; 68(6):2053-8. PubMed ID: 10616976
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
Deng XF; Liu QX; Zhou D; Min JX; Dai JG
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
[TBL] [Abstract][Full Text] [Related]
28. Minimal residual disease in gastric cancer.
Seeliger H; Spatz H; Jauch KW
Recent Results Cancer Res; 2003; 162():79-87. PubMed ID: 12790323
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of micrometastasis in non-small-cell lung cancer.
Coello MC; Luketich JD; Litle VR; Godfrey TE
Clin Lung Cancer; 2004 Jan; 5(4):214-25. PubMed ID: 14967073
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
31. Micrometastases in non-small cell lung cancer (NSCLC).
Passlick B
Lung Cancer; 2001 Dec; 34 Suppl 3():S25-9. PubMed ID: 11740989
[TBL] [Abstract][Full Text] [Related]
32. [Micrometastatic cells in the bone marrow of patients with breast carcinoma].
Diel IJ; Solomayer EF; Bastert G
Radiologe; 2000 Aug; 40(8):681-7. PubMed ID: 11006937
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic cancer: a generalized disease--prognostic impact of cancer cell dissemination.
Bogoevski D; Strate T; Yekebas EF; Izbicki JR
Langenbecks Arch Surg; 2008 Nov; 393(6):911-7. PubMed ID: 18202848
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology.
Jiao X; Krasna MJ
Ann Thorac Surg; 2002 Jul; 74(1):278-84. PubMed ID: 12118789
[TBL] [Abstract][Full Text] [Related]
35. Micrometastatic bone marrow involvement: detection and prognostic significance.
Braun S; Pantel K
Med Oncol; 1999 Sep; 16(3):154-65. PubMed ID: 10523795
[TBL] [Abstract][Full Text] [Related]
36. [Micro-metastases and non-small cell lung cancer].
Saintigny P; Le Pimpec-Barthes F; Bernaudin JF
Rev Mal Respir; 2004 Feb; 21(1):105-16. PubMed ID: 15260043
[TBL] [Abstract][Full Text] [Related]
37. Detection of occult metastases in lung carcinomas: progress and implications for lung cancer staging.
Cote RJ; Hawes D; Chaiwun B; Beattie EJ
J Surg Oncol; 1998 Dec; 69(4):265-74. PubMed ID: 9881945
[TBL] [Abstract][Full Text] [Related]
38. Minimal residual disease in non-small-cell lung cancer.
Hosch SB; Scheunemann P; Izbicki JR
Semin Surg Oncol; 2001 Jun; 20(4):278-81. PubMed ID: 11747269
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
